508 related articles for article (PubMed ID: 19120337)
1. First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study.
van Velsen SG; Haeck IM; Bruijnzeel-Koomen CA; de Bruin-Weller MS
Br J Dermatol; 2009 Mar; 160(3):687-91. PubMed ID: 19120337
[TBL] [Abstract][Full Text] [Related]
2. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R
Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
[TBL] [Abstract][Full Text] [Related]
3. Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial.
Haeck IM; Knol MJ; Ten Berge O; van Velsen SG; de Bruin-Weller MS; Bruijnzeel-Koomen CA
J Am Acad Dermatol; 2011 Jun; 64(6):1074-84. PubMed ID: 21458107
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults.
Hon KL; Ching GK; Leung TF; Chow CM; Lee KK; Ng PC
J Dermatolog Treat; 2009; 20(3):141-5. PubMed ID: 18951236
[TBL] [Abstract][Full Text] [Related]
5. Long-term administration of enteric-coated mycophenolate sodium (EC-MPS; myfortic) is safe in kidney transplant patients.
Salvadori M; Holzer H; Civati G; Sollinger H; Lien B; Tomlanovich S; Bertoni E; Seifu Y; Marrast AC;
Clin Nephrol; 2006 Aug; 66(2):112-9. PubMed ID: 16939067
[TBL] [Abstract][Full Text] [Related]
6. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
Hon KL; Lam MC; Leung TF; Wong KY; Chow CM; Fok TF; Ng PC
Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of enteric-coated mycophenolate sodium in renal transplant patients with diabetes mellitus: post hoc analyses from three clinical trials.
Pietruck F; Budde K; Salvadori M; Sollinger H; Bourbigot B; Gentil MA; Oppenheimer F
Clin Transplant; 2007; 21(1):117-25. PubMed ID: 17302600
[TBL] [Abstract][Full Text] [Related]
8. Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused.
Haeck IM; Timmer-de Mik L; Lentjes EG; Buskens E; Hijnen DJ; Guikers C; Bruijnzeel-Koomen CA; de Bruin-Weller MS
Br J Dermatol; 2007 May; 156(5):979-85. PubMed ID: 17298484
[TBL] [Abstract][Full Text] [Related]
9. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.
Angelova-Fischer I; Hipler UC; Bauer A; Fluhr JW; Tsankov N; Fischer TW; Elsner P
Br J Dermatol; 2006 Jun; 154(6):1112-7. PubMed ID: 16704642
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of enteric-coated mycophenolate sodium in patients with active lupus nephritis.
Mak SK; Lo KY; Lo MW; Chan SF; Tong GM; Wong PN; Wong AK
Nephrology (Carlton); 2008 Jun; 13(4):331-6. PubMed ID: 18476916
[TBL] [Abstract][Full Text] [Related]
11. Tolerability of enteric-coated mycophenolate sodium to 1 year in combination with cyclosporine and corticosteroids in renal transplant recipients.
Rostaing L; Mourad G; Kamar N; Garrigue V; Karras A; Lefrançois N; Charpentier B; Bourbigot B; Pouteil-Noble C; Bayle F; Lebranchu Y; Berthoux F; Le Meur Y; Kessler M; Moulin B; Ducloux D; Delahousse M; Lang P; Merville P; Chaouche-Teyara K; Legendre C;
Transplant Proc; 2006 Nov; 38(9):2860-3. PubMed ID: 17112849
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study.
Hon KL; Leung TF; Ng PC; Lam MC; Kam WY; Wong KY; Lee KC; Sung YT; Cheng KF; Fok TF; Fung KP; Leung PC
Br J Dermatol; 2007 Aug; 157(2):357-63. PubMed ID: 17501956
[TBL] [Abstract][Full Text] [Related]
13. Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults.
Lyakhovitsky A; Barzilai A; Heyman R; Baum S; Amichai B; Solomon M; Shpiro D; Trau H
J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):43-9. PubMed ID: 19552716
[TBL] [Abstract][Full Text] [Related]
14. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
[TBL] [Abstract][Full Text] [Related]
16. Low bone mineral density in adult patients with moderate to severe atopic dermatitis.
Haeck IM; Hamdy NA; Timmer-de Mik L; Lentjes EG; Verhaar HJ; Knol MJ; de Bruin-Weller MS; Bruijnzeel-Koomen CA
Br J Dermatol; 2009 Dec; 161(6):1248-54. PubMed ID: 19673879
[TBL] [Abstract][Full Text] [Related]
17. Severe atopic dermatitis treated with everolimus.
Van Velsen SG; Haeck IM; Bruijnzeel-Koomen CA
J Dermatolog Treat; 2009; 20(6):365-7. PubMed ID: 19954394
[TBL] [Abstract][Full Text] [Related]
18. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
19. Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: a specific marker for severity.
Ezzat MH; Sallam MA; Shaheen KY
Int J Dermatol; 2009 Aug; 48(8):822-9. PubMed ID: 19659860
[TBL] [Abstract][Full Text] [Related]
20. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis.
Jahnz-Rozyk K; Targowski T; Paluchowska E; Owczarek W; Kucharczyk A
Allergy; 2005 May; 60(5):685-8. PubMed ID: 15813816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
